Free tool
FAERS Monitor: Desferal
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016267 or its brand name (Desferal, Deferoxamine Mesylate). Reports on generic versions are filed under their own applications.
Reports
1,676
Serious
1,487
89% of reports
Hospitalization
631
Death reported
334
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- serum ferritin increased157
- pyrexia116
- diarrhoea105
- haemoglobin decreased101
- off label use100
- vomiting90
- nausea87
- death85
- fatigue76
- drug ineffective75
- dyspnoea73
- blood creatinine increased71
- abdominal pain70
- pneumonia65
- malaise64
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 26 |
| 2005 | 27 |
| 2006 | 61 |
| 2007 | 49 |
| 2008 | 70 |
| 2009 | 86 |
| 2010 | 75 |
| 2011 | 102 |
| 2012 | 128 |
| 2013 | 63 |
| 2014 | 98 |
| 2015 | 95 |
| 2016 | 111 |
| 2017 | 114 |
| 2018 | 77 |
| 2019 | 74 |
| 2020 | 66 |
| 2021 | 34 |
| 2022 | 81 |
| 2023 | 62 |
| 2024 | 67 |
| 2025 | 60 |
| 2026 | 49 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,052,483 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| serum ferritin increasedSignal | 157 | 385.0 | 330.9 | 57,978 |
| blood creatinine increasedSignal | 71 | 13.7 | 10.9 | 822 |
| haemoglobin decreasedSignal | 101 | 12.4 | 10.2 | 1,047 |
| pyrexiaSignal | 116 | 4.2 | 3.5 | 285 |
| abdominal painSignal | 70 | 3.8 | 3.0 | 142 |
| pneumoniaSignal | 65 | 2.5 | 2.0 | 59 |
| vomitingSignal | 90 | 2.4 | 2.0 | 74 |
| diarrhoeaSignal | 105 | 2.0 | 1.7 | 56 |
| malaise | 64 | 1.8 | 1.4 | 24 |
| dyspnoea | 73 | 1.6 | 1.3 | 17 |
| off label use | 100 | 1.4 | 1.2 | 13 |
| nausea | 87 | 1.4 | 1.1 | 9 |
| death | 85 | 1.2 | 1.0 | 4 |
| fatigue | 76 | 1.2 | 1.0 | 3 |
| drug ineffective | 75 | 0.7 | 0.6 | 9 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.